What are the ethical frameworks that should guide decision-making regarding the use of antibiotics and the management of antibiotic-resistant infections?

Dec 16, 2024 ... ... infection due to P aeruginosa. Secondary outcomes included all ... Pseudomonas aeruginosa infection. Infect Drug Resist. 2022; 15:655 ... Samples taken should be pre-flush samples which means that they should be taken immediately after the outlet is opened and ideally after a significant period ... Jun 25, 2022 ... Pseudomonas aeruginosa is a multi-drug resistance (MDR) opportunistic pathogens, causing acute or chronic infection in immunocompromised individuals. Some Pseudomonas aeruginosa bacteria are resistant to carbapenem antibiotics, which are often reserved for serious infections. These are called carbapenem- ... P. aeruginosa infection in the hospital manifests primarily as acute lung infection in patients in intensive care units. Models of pseudomonal pneumonia have ... The bacteria are found widely in the environment, such as in soil, water, and plants. They usually do not cause infections in healthy people. If an infection ... Aug 8, 2023 ... Its predilection to cause infections among immunocompromised hosts, extreme versatility, antibiotic resistance, and a wide range of dynamic ... Jul 5, 2018 ... aeruginosa. For many people, a Pseudomonas infection will only cause mild symptoms. However, if a person is in a hospital or has a weakened ... What is Pseudomonas aeruginosa? Pseudomonas aeruginosa (PsA) is a type of bacteria (germ) that is commonly found in soil and water, and likely to live in ... abstract. The wbp gene cluster, encoding the B-band lipopolysaccharide O antigen of Pseudomonas aeruginosa serotype O5 strain PAO1, was previously shown to ...